Skip to main content

Danyelza Prices, Coupons and Patient Assistance Programs

Danyelza (naxitamab) is a member of the miscellaneous antineoplastics drug class and is commonly used for Neuroblastoma.

The cost for Danyelza intravenous solution (gqgk 4 mg/mL) is around $24,324 for a supply of 10 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Danyelza prices

Intravenous Solution

Quantity Per unit Price
10 milliliters $2,432.40 $24,323.96

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Danyelza Coupons, Copay Cards and Rebates

Danyelza offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Danyelza Y-mAbs Connect Co-pay Program

Eligible commercially insured patients may pay $0 per infusion; patients may receive assistance for a total of 12 months from the date of enrollment; maximum savings of $15,000; for additional information contact the program at 833-339-6227.

Applies to:
Danyelza
Number of uses:
12 months from date of enrollment

Form more information phone: 833-339-6227 or Visit website

Patient Assistance & Copay Programs for Danyelza

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Y-mAbs Connect Patient Support Program

Eligibility requirements:
  1. Must be uninsured or underinsured
  2. At or below 600% of FPL
  3. Medically Necessary as determined by a Doctor
  4. Must be residing in the US or US territory
  5. Co-payment assistance, patient support, and patient assistance programs are available for eligible patients.
Applicable drugs:
  • Danyelza (naxitamab-gqgk) Injection; IV

More information please phone: 833-339-6227 Visit Website